Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors of gene-resistant mutations in different nucleosides.

Hepato-gastroenterology - 1 Jan 2000

An Ping, Bian Li, Yin Bo, Lv Dan, Cao Yan-Xue, Wu Xing

Abstract excerpt

BACKGROUND/AIMS: To explore the risk factors of gene-resistant mutations during nucleotide treatment. METHODOLOGY: A total of 320 patients with CHB were randomly divided into lamivudine (LAM, 107 cases), adefovir (ADV, 106 cases) and entecavir (ETV, 107 cases) groups, and P gene mutations of HBV were regularly detected. Kaplan-Meier and Cox regression analysis were performed. RESULTS: There was no statistical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Gene Products, pol
Share to Guanine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Kaplan-Meier Estimate

Share to Lamivudine

Share to Organophosphonates

Share to Proportional Hazards Models

Source

Identifiers

PMID: 22260834
DOI: 10.5754/hge11247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors of gene-resistant mutations in different nucleosides.PMID 22260834Read ↗

[Analysis of risk factors for drug resistant mutations in the reverse transcriptase region in chronic hepatitis B virus-infected patients].Semantic proximity Read ↗

Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016).Semantic proximity Read ↗

Drug Resistance Mutations in the Polymerase Gene of HBV in Three Generations of Patients with Chronic Hepatitis BSemantic proximity Read ↗

Multilocus drug resistance mutation analysis in 148 HBV patients in northern Henan Province of ChinaSemantic proximity Read ↗

Comparison of Detection Rate and Mutational Pattern of Drug-Resistant Mutations Between a Large Cohort of Genotype B and Genotype C Hepatitis B Virus-Infected Patients in North China.Semantic proximity Read ↗

Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment.Semantic proximity Read ↗

[Analysis of characteristics of drug resistance gene mutation in HBV RT region of hepatitis B infected patients].Semantic proximity Read ↗

Drug Resistance Mutations in the Polymerase Gene of Hepatitis B Virus in Three Generations of Patients with Chronic Hepatitis BSemantic proximity Read ↗

[Drug-resistant mutations in hepatitis B virus found in chronic HBV carriers using PCR sequencing technology].Semantic proximity Read ↗

Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.Semantic proximity Read ↗

Mutations in Pol gene of hepatitis B virus in patients with chronic hepatitis B before and after therapy with nucleoside/nucleotide analogues.Semantic proximity Read ↗

Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/ nucleotide analogue treatment among Chinese chronic hepatitis B patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.